INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

21,570 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
1,246 sh
Feb 9, 2026Feb 11, 2026
Page 401 of 540
← PrevNext →
traded Feb 9, 2026
+2d
SEC Form 4

Evidence

15
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$382K
8,731 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

15
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$391K
9,114 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$5,445
32 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$66K
133 sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$4,210
24 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
177 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
190 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$438K
563 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$405K
521 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$304K
391 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

9
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$718K
47.2K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

8
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$161K
16.2K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

4
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$59K
75 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$113K
144 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$160K
205 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

3
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
2,756 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$42K
53 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
1,076 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$20K
26 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$29K
37 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
2,500 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$785
1 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$16K
20 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

44
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Open-market sale
SELL$2.36M
12.0K sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

42
John J. McGuire IIIRSpouse
MSFTMICROSOFT CORP
Partial sale
SELL$1,001 – $15KJan 30, 2026Feb 10, 2026
traded Jan 30, 2026
+11dHouse PTR

Evidence

35
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Open-market sale
SELL$541K
5,118 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

31
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Open-market sale
SELL$521K
5,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

25
John J. McGuire IIIRSpouse
WMTWalmart Inc.
Partial sale
SELL$1,001 – $15KJan 20, 2026Feb 10, 2026
traded Jan 20, 2026
+21dHouse PTR

Evidence

21
WA
Wilson John J. AddingtonCHIEF OPERATING OFFICER
RPIDRAPID MICRO BIOSYSTEMS, INC.
Open-market sale
SELL$17K
4,610 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

12
SS
Smith Brian ScottPresident, Hearth & Home Tech
HNIHNI CORP
Open-market sale · 10b5-1 plan
SELL$104K
2,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

12
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$54K
5,000 sh
Feb 5, 2026Feb 10, 2026
traded Feb 5, 2026
+5dSEC Form 4

Evidence

10
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$58K
2,056 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

8
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
30.0K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

8
SN
Schmitt Thomas NCPO, Skyward Group
SKWDSkyward Specialty Insurance Group, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
2,616 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

4
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
1,836 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
6,894 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

1
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
5,000 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$8,086
3,379 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence